Form 8-K Celldex Therapeutics, For: Aug 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Celldex Therapeutics (CLDX) Reports In-Line Q2 EPS
August 7, 2014 7:53 AM EDTCelldex Therapeutics (NASDAQ: CLDX) reported Q2 EPS of ($0.32), in-line with the analyst estimate of ($0.32). Revenue for the quarter came in at $592 thousand versus the consensus estimate of $340 thousand.
For earnings history and earnings-related data on Celldex Therapeutics (CLDX) click here.
... More